Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
levetiracetam, Quantity: 1000 mg
Strides Pharma Science Pty Ltd
Levetiracetam
Tablet, film coated
Excipient Ingredients: magnesium stearate; colloidal anhydrous silica; povidone; purified talc; maize starch; titanium dioxide; hypromellose; macrogol 400
Oral
60
(S4) Prescription Only Medicine
It is indicated for:,? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME),and,? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).
Visual Identification: White, modified oval shaped, biconvex film-coated tablets debossed with a deep break line separating 'E' & '13' on one side & plain on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Registered
2011-12-23